We discuss strategies that incorporate cytokine engineering, metabolic reprogramming, and logic-gated activation to counteract the immunosuppressive tumor microenvironment.
First-pass extracted concept
Cytokine engineering
Candidate: concept label1 source documents3 linked claims
Live refresh every 5sNext refresh in 5s
Evidence Snippets
Supporting Sources
Linked Claims
Synthetic modulation of cytokine and co-stimulatory pathways enhances CAR-T potency while reducing exhaustion and toxicity.
Cytokine engineering, metabolic reprogramming, and logic-gated activation are discussed as strategies to counteract the immunosuppressive tumor microenvironment.
Integrating cytokine and growth factor pathways enables safer, more durable, and scalable next-generation CAR-T therapies for hematologic and solid tumors.